Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Melatonin-based therapeutics for atherosclerotic lesions and beyond: Focusing on macrophage mitophagy
Amir Ajoolabady, Yaguang Bi, David Julian McClements, et al.
Pharmacological Research (2022) Vol. 176, pp. 106072-106072
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Mitophagy in cardiovascular diseases: molecular mechanisms, pathogenesis, and treatment
Amir Ajoolabady, Mario Chiong, Sergio Lavandero, et al.
Trends in Molecular Medicine (2022) Vol. 28, Iss. 10, pp. 836-849
Open Access | Times Cited: 121
ER stress and inflammation crosstalk in obesity
Amir Ajoolabady, Cynthia Lebeaupin, Ne N. Wu, et al.
Medicinal Research Reviews (2022) Vol. 43, Iss. 1, pp. 5-30
Closed Access | Times Cited: 56
Melatonin: Facts, Extrapolations and Clinical Trials
Jean A. Boutin, David J. Kennaway, Ralf Jockers
Biomolecules (2023) Vol. 13, Iss. 6, pp. 943-943
Open Access | Times Cited: 37
Mitophagy in atherosclerosis: from mechanism to therapy
Yanhong Zhang, Jiajun Weng, Luyao Huan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 32
Inflammaging: mechanisms and role in the cardiac and vasculature
Amir Ajoolabady, Domenico Praticò, Manlio Vinciguerra, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 6, pp. 373-387
Open Access | Times Cited: 21
Melatonin Treatment in Kidney Diseases
Magdalena Markowska, Stanisław Niemczyk, Katarzyna Romejko
Cells (2023) Vol. 12, Iss. 6, pp. 838-838
Open Access | Times Cited: 17
Targeted delivery of rosuvastatin enhances treatment of HHcy-induced atherosclerosis using macrophage membrane-coated nanoparticles
Dayue Liu, Anning Yang, Yulin Li, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 9, pp. 100937-100937
Open Access | Times Cited: 6
Effects of mitochondrial dysfunction on cellular function: Role in atherosclerosis
Minwen Xu, Wenjun Wang, Jingpei Cheng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116587-116587
Open Access | Times Cited: 5
Epigenetic modification in alcohol‐related liver diseases
Amir Ajoolabady, Hamid Aslkhodapasandhokmabad, Yuan Zhou, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 4, pp. 1463-1491
Closed Access | Times Cited: 22
Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities
Pingping Yang, Jun Ren, Lifang Yang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5205-5205
Open Access | Times Cited: 12
Melatonin as an adjunctive therapy in cardiovascular disease management
Zan Luo, Yuan Tang, Liang Zhou
Science Progress (2024) Vol. 107, Iss. 4
Open Access | Times Cited: 4
Xinmaikang-mediated mitophagy attenuates atherosclerosis via the PINK1/Parkin signaling pathway
Yanhong Cao, Xin Chen, Fuqiang Pan, et al.
Phytomedicine (2023) Vol. 119, pp. 154955-154955
Closed Access | Times Cited: 10
Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome
Na Zheng, Yihao Long, Zixuan Bai, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
New Perspectives on the Role and Therapeutic Potential of Melatonin in Cardiovascular Diseases
Pengchen Gu, Yuxin Wu, Weiwei Lu
American Journal of Cardiovascular Drugs (2024) Vol. 24, Iss. 2, pp. 171-195
Closed Access | Times Cited: 3
PCSK9 in metabolism and diseases
Amir Ajoolabady, Domenico Praticò, Mohsen Mazidi, et al.
Metabolism (2024) Vol. 163, pp. 156064-156064
Closed Access | Times Cited: 3
FUN14 Domain Containing 1 (FUNDC1): A Promising Mitophagy Receptor Regulating Mitochondrial Homeostasis in Cardiovascular Diseases
Yu Mao, Jun Ren, Lifang Yang
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
The Therapeutic Strategies Targeting Mitochondrial Metabolism in Cardiovascular Disease
Xiaoyang Huang, Zhenhua Zeng, Siqi Li, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2760-2760
Open Access | Times Cited: 14
Melatonin ameliorates atherosclerosis by suppressing S100a9-mediated vascular inflammation
Liyuan Chen, Xue Wang, Chang Liu, et al.
European Journal of Pharmacology (2023) Vol. 957, pp. 175965-175965
Closed Access | Times Cited: 7
MST4 promotes proliferation, invasion, and metastasis of gastric cancer by enhancing autophagy
Pengwei Liu, Lin Li, Wei Wang, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e16735-e16735
Open Access | Times Cited: 5
Psycho-Neuro-Endocrine-Immunology: A Role for Melatonin in This New Paradigm
Oscar Kurt Bitzer-Quintero, Genaro Gabriel Ortíz, Socorro Jaramillo-Bueno, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4888-4888
Open Access | Times Cited: 8
Melatonin Ameliorates Atherosclerotic Plaque Vulnerability by Regulating PPARδ‐Associated Smooth Muscle Cell Phenotypic Switching
Sy‐Jou Chen, Hung‐Che Chien, Shih‐Hung Tsai, et al.
Journal of Pineal Research (2024) Vol. 76, Iss. 5
Closed Access | Times Cited: 1
Plasma Proteomic Biomarkers in Alzheimer’s Disease and Cardiovascular Disease: A Longitudinal Study
Laurie A. Theeke, Ying Liu, Silas Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10751-10751
Open Access | Times Cited: 1
Atherosclerosis: From the Disruption of Mitochondrial Membrane Potential to the Potential Interventional Strategies
Dexiang Xia, Yanmei Chen, Guifang Luo, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 38, pp. 4355-4373
Closed Access | Times Cited: 3
FEATURES OF RELATIONS OF MELATONIN WITH THE STATE OF INTRACELLULAR REGULATORSOF THE FUNCTIONAL ACTIVITY OF WHOLE BLOOD MONONUCLEAR CELLS IN CORONARY HEART DISEASE
А. В. Логаткина, В. С. Никифоров, И. Терехов
Problems of Biological Medical and Pharmaceutical Chemistry (2024) Vol. 27, Iss. 2, pp. 15-22
Closed Access
Targeting the circadian modulation: novel therapeutic approaches in the management of ASD
Yuxing Zhang, Y. J. Chen, Wu Li, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top